Shareholders Equity: The sum of preferred and common equity items.
OS Therapies Incorporated (OSTX) had Shareholders Equity of $6.75M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.54M |
|
-- |
|
-- |
|
$4.84M |
|
$-4.84M |
|
$0.30M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.54M |
|
$-4.84M |
|
$-4.73M |
|
25.11M |
|
25.11M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$3.55M |
|
$0.00M |
|
$6.76M |
|
$10.31M |
|
$3.46M |
|
-- |
|
$0.10M |
|
$3.56M |
|
$4.94M |
|
$-0.00M |
|
|
Shareholders Equity |
$6.75M |
29.66M |
|
| Cash Flow Statement Financials | |
$-5.80M |
|
$-0.47M |
|
$3.54M |
|
$5.53M |
|
$2.80M |
|
$-2.73M |
|
$2.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.77% |
|
-- |
|
-44.00% |
|
-67.18% |
|
$0.23 |
|
$-0.23 |
|
$-0.23 |
|